NCT05050981View on ClinicalTrials.gov

Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Menopause
Interventions
DRUG

Hormone replacement therapy

Hormone replacement therapy: menopause hormone therapy with estrogen-only or oestrogen-progestin.

DRUG

Selective serotonin reuptake inhibitors

Selective serotonin reuptake inhibitors: anyone in the category, e.g.: fluoxetine, sertraline, etc.

Trial Locations (1)

09760-280

Centro de Atenção Integral à Saúde da Mulher, São Bernardo do Campo

All Listed Sponsors
lead

Faculdade de Medicina do ABC

OTHER

NCT05050981 - Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life | Biotech Hunter | Biotech Hunter